Acquisitions - Summary of Initial Consideration Recognized and Fair Value of Assets Acquired (Details) - Mantle Therapeutics Inc. $ in Thousands |
Sep. 29, 2026
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Initial cash consideration paid | $ 5,009 |
| Final cash consideration payable (receivable), estimated | (10) |
| Net liabilities assumed, estimated | 321 |
| Fair value of shares of the Company's common stock issued | 2,165 |
| Fair value of Contingent Consideration Liabilities | 1,267 |
| Transaction costs, estimated | 1,122 |
| Consideration paid | 9,874 |
| Assets acquired: | |
| Total assets acquired | 9,874 |
| IPR&D Assets | |
| Assets acquired: | |
| Acquired in-process research and development | $ 9,874 |
| X | ||||||||||
- Definition Business combination, cash consideration payable (receivable). No definition available.
|
| X | ||||||||||
- Definition Business combination fair value of contingent consideration liability. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of identifiable indefinite-lived intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|